Purpose of review Recent literature focused on prescription opioids has neglected sex differences in use. Here, we evaluated the recent literature (since 2015) examining sex differences in prescription opioid use.
INTRODUCTION
The prevalence of opioid use globally among adults is 0.7%, representing approximately 33 million users [1] . Prescription opioid use has become a public health concern due to an increase in morbidity and mortality [2] , especially in the United States where opioid-related deaths have quadrupled since 1999 [3] . Every day, approximately 91 people die from opioid overdose [4] , and over 1000 people are treated for prescription opioid misuse in the emergency department (ED). This is an example of how certain forms of drug use may change in their prevalence and health impacts. Although men are more likely to die from prescription overdose than women [5] , overdoses related to opioids have greatly increased in women compared with men [6] ; further, women are approximately twice as likely to be prescribed prescription opioids compared with men [7] . In addition, pain sensitivity varies between men and women, with women reporting more chronic conditions that cause pain [8] ; these conditions may be associated with higher prescription rates of opioids. Understanding sex differences related to prescription opioid use is important because differences in use by sex can result in differential consequences that matter such as serious morbidity and mortality. Despite the importance of these sex differences, there has been little attention to how such sex differences impact both risk factors for and outcomes of opioid use.
Between early 2015 and late 2016, we identified only eight articles (Table 1 ) published in English that address sex and prescription opioid use, though there may be additional published articles written in other languages. The current publications identified included two scoping reviews, two clinic-based studies, and four population-based studies that
The scoping review by Hemsing et al. identified 57 articles published between 1990 and 2014, which examined risk factors for pain and misuse of prescription opioids among women. A majority of the studies identified in this review were descriptive with only a few interventional studies targeting pain, trauma, and misuse of prescription opioids. Those who had experienced violence and trauma, aboriginal women, pregnant women, women who are sexual minorities (i.e., lesbian and bisexual), and trans-sex women were all at heightened risk for pain and misuse of prescription opioids according to this review [9] . A second review authored by Graziani and Nistico summarized literature published between 1995 and 2015 to analyze sex differences in the pharmacokinetic and pharmacodynamic effects of oxycodone and hydrocodone. This review suggested that there has been an increase in oxycodone and hydrocodone abuse among women but found no differences in pharmacokinetic or pharmacodynamic effects by sex [10] . This indicates that there is some factor other than biological differences in the processing of opioids that accounts for the difference in prescription opioid abuse between men and women.
Clinic-based studies
The two clinic-based studies examined sex differences among individuals misusing opioids. Bawor et al. used data from a multicenter cohort study (n ¼ 503). Participants receiving methadone treatment who met Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) [11] criteria for opioid dependence disorder were used in their regression models and descriptive statistical analyses to examine past 30-day opioid use (this could include illicit or prescription opioids). The authors found women compared with men were more likely to have a family history of mental illness and to initiate opioid use through a physician. Alternatively, men were found to have higher rates of cigarette smoking and cannabis use compared with women [12 && ]. The other clinic-based study used a cross-sectional method to interview 162 participants as part of a 7-week inpatient and 12-week outpatient study. Participants who met DSM-IV criteria for opioid dependence in the past 6 months (prescription opioids with or without heroin) were included in the descriptive statistics, t tests, and chi-square analyses. The authors found 60% of the participants had back pain, women had greater psychiatric comorbidity and endorsed greater pain compared with men, whereas men reported more antisocial behaviors such as police arrests compared with women [13] .
Population-based studies
Of the four population-based studies that considered sex effects, Fink et al. examined crosssectional data from the National Survey on Drug Use and Health, which is conducted annually in the United States. In the 2011-2012 cohort (n ¼ 113 665), analyzed using multinomial logistic regression for past year misuse of prescription opioids, misuse of prescription opioids and major depressive episodes (MDE) were prevalent among women but not for men [14 & ]. In addition, polydrug use was found to be more prevalent among those with comorbid misuse of prescription opioids and MDE than persons with prescription opioid misuse alone or MDE alone. Evans et al. used a retrospective cohort design conducted in California (n ¼ 20 758) to examine risks for mortality by sex by linking vital statistics data to individuals who were admitted to a publicly funded opioid treatment program (any type of opioid) in California between 2006 and 2010. Using standardized mortality ratios and Cox proportional hazards, authors determined effects of sex on hazard of all-cause mortality. They reported an increased risk of mortality from opioid use among those being treated for opioid dependence. Further, full-time employment decreased mortality risk, and medical problems increased mortality risk among men. For women, concurrent opioid and methamphetamine/cocaine use increased mortally risk
KEY POINTS
There is limited research focusing on sex differences and opioid use; current research has primarily been conducted in North America.
The current research confirmed the importance of depression among women and cancer among men.
Similar to the recent literature, stratification by sex identified woman to be more likely to report prescription opioid use compared with men (54.9 vs. 42.2%) in a community sample.
Prevalence of back pain and cancer were higher among women, further significant risk factors for noncurrent opioid use include history of back pain and cancer whereas risk factors of current prescription use include doctor visits. [15] . The third population-based study was conducted in British Colombia, Canada by Gladstone et al. [16] using an ecological method. Data from British Colombia PharmaNet an information system on prescription drug dispensations and cause of death from vital statistics records were used to identify patterns and geographic areas in prescription opioid dispensations to individuals who suffered a prescription opioid-related death between 2004 and 2013. The authors found that relationship between prescription opioid dispensing and rates of unintentional death was significant for both sexes, with the exception that opioid-related deaths for men were more likely due to their using diverted pills [16] . The remaining population-based crosssectional study by LeResche et al. [17 & ] examined sex and age differences in pain status among chronic opioid therapy users. Participants (n ¼ 2163) who were enrolled in chronic opioid therapy for at least 1 year and filled an opioid prescription within the last 30 days completed a telephone survey relating to their pain level and functioning status; findings included women reporting higher pain levels compared with men. Specifically, the authors found young-aged and middle-aged women were at highest risk for pain among those receiving chronic opioid therapy [17 & ].
The recent literature reviewed here has examined sex differences in prescription opioid use; however, significant challenges to the field remain. One challenge includes the geographic homogeneity of most studies. Research on opioid use and sex has primarily been conducted among populations in North America though other parts of the globe such as Afghanistan [18] , Australia [19] , and other countries are also affected by opioid use. In the future, there may be more information available from these countries with regards to sex differences due to new studies that are currently being conducted [20] .
In addition, research in this area typically examines only the 'tip of the iceberg'; or those cases that are clinical cases or cases brought to the attention of clinicians or the ED. Finally, there are challenges in the interpretation of the findings of opioid use research when we have inconsistent nomenclature resulting from a broad range of terminology that describes 'use', misuse, abuse, and dependence.
Population-based studies can be useful for addressing the gap between sex differences and prescription opioid use; they can provide information from broad population groups to help identify factors that can influence effectiveness of interventions. We add to this review through analysis of original data from North Central Florida that addresses sex differences in prescription opioid use. We examine risk factors for prescription opioid use including differences by sex in rates of pain, depression, and cancer among a community-based sample addressing common risk factors in the literature. The variables we are using in our analyses are shown in Table 2 .
METHODS FOR COMMUNITY-BASED STUDY

Statistical analyses
SAS version 9.4 (SAS Institute Inc., Cary, NC, USA) [21] was used for analysis with chi-square tests of independence. An independent t test compared mean ages. Multinomial and multivariate logistic regressions were used to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS
Among the sample of 8470, 58.6% were women, 61.3% black, 60.0% had at least a high school education, 27.5% reported depression, 43.6% reported back pain, 8.0% were cancer survivors, 32.6% had visited an ED in the last 6 months, 66.5% had visited a doctor in the last 6 months, and 23.5% reported binge drinking in the past 30 days. Approximately half (49.7%) reported prescription opioid use in their lifetime; 13.7% reported past 30-day use (Table 3) . When stratified by sex, we found statistically significant associations for all variables with the exception of age. Women compared with men were significantly more likely to be white, educated, depressed, report back pain, and cancer and report visiting the ED and doctor in the past 6 months. Men were more likely to report current binge drinking than women. Regarding opioid use, women were more likely than men to report recent (past 30 days) and nonrecent (lifetime but not past 30 days) prescription opioid use (54.9% women vs. 42.2% men). Table 4 provides results of the adjusted multinomial logistic regression model predicting lifetime use of prescription opioids and past 30-day prescription opioid use with never use as the reference group for the regression. After adjustment for covariates, women were significantly more likely to report both lifetime and past 30-day use of prescription opioids compared with men. In addition, risk factors for lifetime use of prescription opioids included older age, being white, more educated, history of depression, past 6-month doctor and ED visits, and past 30-day binge drinking. The strongest risk factor for lifetime use of prescription opioids was history of back pain with those who reported such a history being 1.66 times as likely to report lifetime use of prescription opioids (95% CI, 1.50-1.85) compared with those with no history of back pain. Following history of back pain, cancer was the second strongest risk factor for lifetime use of prescription opioids (adjusted OR: 3.66; 95% CI, 2.97-4.51).
Risk factors for past 30-day use of prescription opioids yielded similar results to lifetime use of prescription opioids including older age, being white, and having a history of depression. Those with back pain were 2.85 times more likely to report past 30-day use of opioids compared with those without history of back pain (95% CI, 2.45-3.32). History of cancer, visiting the ED in the past 6 months, and binge drinking were also risk factors for past 30-day prescription opioid use. Seeing a doctor in the past 6 months was the strongest risk factor for past 30-day use of prescription opioid use, with a visit increasing the odds nearly four times over those who did not visit a doctor (adjusted OR: 3.66; 95% CI, 2.97-4.51). We ran a separate logistic regression stratified by sex (results not shown) and found that the majority of the risk factors remained the same for men and women with the exception of cancer among women that had a lower association with opioids compared with that for men (adjusted OR: 0.46; 95% CI, 0.36-0.59).
DISCUSSION
The use of prescription opioids continues to be a significant public health problem contributing to a number of poor health outcomes. Upon examining the recent literature, we were only able to identify eight publications regarding sex differences in prescription opioid use. The challenges identified within this field of research include geographic homogeneity, primary focus on opioid-dependent populations, discrepancy in terminology for reporting use, and the limited amount of epidemiologic Table 3 . Characteristics of HealthStreet members stratified by sex (n ¼ 8470) data available for addressing sex and prescription opioid use. We had the opportunity to address some of these challenges by using a community-based study to further examine sex differences in prescription opioid use. HealthStreet is an ongoing community engagement program that recruits community members and conducts real-time assessment on their health conditions and concerns. Using HealthStreet and this community-based sample, we were able to assess sex-based patterns of prescription opioid use. This current analysis shows that approximately half of the community sample had used prescription opioids in their lifetime. The prevalence of past 30-day prescription opioid use (13.7%) was higher than what previous national surveys have reported (6.9%) [22] . However, consistent with the findings of the recent literature examined, we found that women were more likely to report use of prescription opioids compared with men. In accordance with findings from LeResche et al. [17 & ] and Fink et al. [14 & ], we also found that women were more likely to report chronic health conditions including pain and depression.
Further, this analysis demonstrates that there are differences in prescription opioid use and patterns of use between sexes. Women not only had higher rates of prescription opioid use currently but also before the past 30 days compared with men, consistent with the national trends which puts them at risk for being prescribed these medications. In addition, the literature reports pain sensitivity differed by sex with women reporting lower pain sensitivity than men [23, 24] and more chronic conditions that cause pain [8] which are associated with pain pill use. Previous studies have also found men to be less likely to seek help from health professionals [25] which may be the reason women are also more likely to be prescribed and to use prescription opioids [26] . In contrast to previous findings, our results also showed more women in the sample reported cancer compared with men [27] ; however, we found women with cancer had a significantly reduced risk of using opioids compared with men. This suggests that women using prescription opioids are using them for indications other than cancer or could reflect differential mortality from cancer. Further research is needed to investigate opioid use by cancer status.
There are a few limitations to these findings. The cross-sectional nature of the data limits the ability to establish temporality between prescription opioid use and several variables described above. Self-report of prescription opioid use only was assessed; without information regarding misuse or dependence. However, strengths of this analysis include use of a community-based sample in examining sex differences and prescription opioid use. We contribute to the literature by providing data from a large sample that addressed risks for both lifetime and 30-day use.
CONCLUSION
Only eight recent studies have been published that cover sex differences related to prescription opioid use. Findings from the literature and our data suggest women are more likely to use prescription opioids compared with men. There is limited information on sex differences in opioid use risk factors and outcomes and more studies focused on this aspect are warranted.
